![]() |
市场调查报告书
商品编码
1701929
下腔静脉过滤器市场按产品、材料、应用(治疗静脉血栓栓塞、预防肺栓塞等)、最终用户(医院、门诊手术中心等)和地区划分,2024 年至 2032 年Inferior Vena Cava Filter Market by Product, Material, Application (Treatment Venous Thromboembolism, Prevent Pulmonary Embolism, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032 |
2024 年全球下腔静脉 (IVC) 过滤器市场规模达 7.69 亿美元。展望未来, IMARC Group预计到 2033 年市场规模将达到 14.09 亿美元,2025-2033 年期间的成长率 (CAGR) 为 7%。深部静脉栓塞 (DVT) 和肺栓塞 (PE) 盛行率的不断上升、消费者对疾病风险和后果的认识不断提高、对微创手术的偏好日益增加是推动市场发展的一些主要因素。
下腔静脉 (IVC) 过滤器是一种医疗设备,旨在防止血栓从下半身迁移到肺部并降低肺栓塞的风险。它是一种由金属或合成材料製成的小型笼状结构。它被插入下腔静脉,将脱氧血液从下半身输送到心臟。它透过捕获血块并阻止其进入肺部来充当物理屏障。
目前,血栓高风险患者越来越多地采用 IVC 过滤器,这促进了市场的成长。除此之外,由于医疗保健提供者的优惠报销政策,IVC 过滤器的使用率不断上升,推动了市场的成长。此外,由于老年人更容易发生静脉血栓栓塞,因此越来越多地采用 IVF 过滤器,这也促进了市场的成长。此外,由于全球大众对微创手术的偏好日益增加,对 IVC 过滤器的需求不断增长,这对市场产生了积极影响。此外,由于医疗基础设施的改善,医疗解决方案的采用率不断提高,从而增强了市场的成长。
深部静脉血栓(DVT)和肺栓塞(PE)盛行率上升
由于全球深部静脉栓塞 (DVT) 和肺栓塞 (PE) 的盛行率不断上升,对 IVC 过滤器的需求也在增加。深部静脉血栓形成通常发生在深层静脉(通常在腿部)形成血栓时。此外,如果这些血块脱落并进入肺部,则可能导致一种称为肺栓塞的危及生命的疾病。由于久坐不动的生活方式、肥胖、不当的体力活动和其他生活方式相关问题,人们面临越来越多的 DVT 和 PE 病例。此外,老年族群罹患 DVT 的几率也会增加。此外,医疗保健提供者越来越多地采用 IVC 过滤器作为高风险患者的预防措施,以减少 PE 的发生及其相关发病率和死亡率。
提高消费者对疾病风险和后果的认识
随着医疗专业人员和一般民众对 DVT 和 PE 的风险和后果的认识不断提高,对 IVC 过滤器的需求也在增加。
各国管理机构正在透过传播意识、组织活动和采取教育措施来鼓励采用下腔静脉过滤器,重点是预防静脉血栓栓塞症。此外,诊断能力的快速进步使得能够更准确、及时地检测 DVT 和 PE 病例,从而改善患者的治疗效果。此外,早期诊断可以让医疗专业人员识别出哪些人可以从 IVC 过滤器植入中受益。下腔静脉过滤器的使用率不断提高,为预防肺栓塞提供了可靠且有效的解决方案,促进了市场的成长。
IVC 过滤器技术的进步
各製造商正在迅速推进 IVC 过滤技术,以提高产品的安全性和有效性。此外,可回收下腔静脉过滤器的使用日益增多,一旦肺栓塞风险消除,就可以取出。这些可回收过滤器为医疗保健专业人员提供了更多灵活性和有效管理患者的选择,这带来了积极的市场前景。此外,过滤器设计和材料的各种技术进步有助于增强生物相容性并降低不良反应和长期併发症的风险。除此之外,由于其有效性的提高,IVC 过滤器在适当情况下的采用率也在上升。
The global inferior vena cava (IVC) filter market size reached USD 769.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,409.0 Million by 2033, exhibiting a growth rate (CAGR) of 7% during 2025-2033. The growing prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE), rising consumer awareness about the risks and consequences of diseases, and increasing preference for minimally invasive surgical procedures are some of the major factors propelling the market.
An inferior vena cava (IVC) filter is a medical device that is designed to prevent the migration of blood clots from the lower body to the lungs and reduce the risk of pulmonary embolism. It is a small and cage-like structure that is manufactured from metal or synthetic materials. It is inserted into the inferior vena cava vein that carries deoxygenated blood from the lower body to the heart. It acts as a physical barrier by trapping blood clots and preventing them from reaching the lungs.
At present, the increasing adoption of IVC filters among patients who are at high risk of developing blood clots is contributing to the growth of the market. Apart from this, the rising utilization of IVC filters on account of favorable reimbursement policies by healthcare providers is propelling the growth of the market. Moreover, the increasing adoption of IVF filters among the geriatric population, as they are more prone to venous thromboembolism, is bolstering the growth of the market. Additionally, the growing demand for IVC filters due to the increasing preference for minimally invasive surgical procedures among the masses around the world is positively influencing the market. Furthermore, the rising adoption of medical treatment solutions due to the improving healthcare infrastructure is strengthening the growth of the market.
Rising prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE)
There is a rise in the demand for IVC filters due to the increasing prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE) among the masses across the globe. Deep vein thrombosis usually occurs when blood clots form in deep veins, often in the legs. Moreover, if these clots break loose and travel to the lungs, then they can cause a life-threatening condition known as pulmonary embolism. People are increasingly facing DVT and PE cases due to sedentary lifestyles, obesity, improper physical activity, and other lifestyle-related issues. Additionally, there is an increased chance of the development of DVT among the geriatric aging population. Furthermore, healthcare providers are increasingly adopting IVC filters as a preventive measure for high-risk patients to reduce the occurrence of PE and its associated morbidity and mortality.
Increasing consumer awareness about the risks and consequences of diseases
There is an increase in the demand for IVC filters due to the rising awareness about the risks and consequences of DVT and PE among healthcare professionals and the general population.
Governing agencies of various countries are encouraging the adoption of IVC filters by spreading awareness, organizing campaigns, and taking educational initiatives to focus on venous thromboembolism prevention. Moreover, rapid advancements in diagnostic capabilities allow more accurate and timely detection of DVT and PE cases that enhances patient outcomes. In addition, early diagnosis allows healthcare professionals to identify individuals who could benefit from IVC filter placement. The rising utilization of IVC filters to provide a reliable and effective solution for preventing pulmonary embolism is contributing to the growth of the market.
Advancements in IVC filter technology
Various manufacturers are rapidly advancing IVC filter technology to provide improved safety and efficacy of the product. In addition, the rising introduction of retrievable IVC filters, which can be removed once the risk of pulmonary embolism has settled. These retrievable filters provide healthcare professionals with more flexibility and options for managing patients effectively, which is offering a positive market outlook. Additionally, various technological advancements in filter design and materials assist in enhancing biocompatibility and reducing the risk of adverse reactions and long-term complications. Apart from this, the rising adoption rates of IVC filters for appropriate cases due to their enhanced effectiveness.
Retrievable IVC filter represents the largest market segment
Retrievable IVC filters are medical devices that are designed to be implanted temporarily in patients at high risk of pulmonary embolism. They can be removed once the risk of clot migration has subsided or when the condition of the patient is improved. In addition, the retrievable IVC filter placement procedure is minimally invasive and typically performed by an interventional radiologist. The rising adoption of retrievable IVC filters, as they offer flexibility to healthcare providers in treatment options, is propelling the growth of the market.
Non-ferromagnetic material accounts for the majority of the market share
Non-ferromagnetic materials are those that do not contain iron and do not exhibit magnetic properties. They are used to construct filter devices and offer enhanced biocompatibility. They can withstand the physiological environment within the human body without causing adverse reactions. In addition, they are widely used in medical settings where the presence of magnetic materials could interfere with imaging techniques, such as magnetic resonance imaging (MRI). Non-ferromagnetic materials are utilized in the construction of IVC filters that allow patients to undergo MRI scans without any concerns about potential complications or distortions in the images.
Treatment venous thromboembolism (VTE) holds the biggest market share
In the treatment venous thromboembolism (VTE), the IVC filters are placed in the inferior vena cava that carries deoxygenated blood from the lower body to the heart, to trap blood clots and prevent their migration to the lungs. They assist in reducing the risk of pulmonary embolism and its potential consequences in the body. They also provide an additional layer of protection against blood clot migration in high-risk patients. In line with this, VTE treatment provides enhanced patient outcomes and improved overall safety in managing VTE cases.
Hospitals dominate the market share
Hospitals are the primary end-users of IVC filters, as they provide enhanced treatment options to patients with various medical conditions, such as those at high risk of venous thromboembolism (VTE). In hospitals, IVC filters are widely utilized in patients undergoing surgical procedures or those admitted for trauma or critical care, and individuals with known risk factors for developing deep vein thrombosis (DVT) or pulmonary embolism (PE). In addition, hospitals are equipped with advanced medical technologies and experienced healthcare professionals that benefit in managing VTE cases effectively. Interventional radiologists or vascular surgeons often perform the minimally invasive procedure of inserting IVC filters in hospital settings.
North America exhibits a clear dominance, accounting for the largest inferior vena cava (IVC) filter market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America held the biggest market share due to the presence of well-established healthcare infrastructure and facilities. In addition, the rising prevalence of obesity among individuals is contributing to the growth of the market in the region. Apart from this, the increasing utilization of IVC filters as a preventive measure among patients is supporting the growth of the market. In line with this, the rising adoption of IVC filers due to favorable regulatory framework and reimbursement policies is bolstering the growth of the market in the North America region.
Key players in the industry are investing in research and development (R&D) activities to improve the design, materials, and safety features of IVC filters. In line with this, they are developing retrievable filters, enhancing the biocompatibility of products, and exploring innovative filter designs to reduce complications and enhance patient outcomes. Apart from this, many companies are launching new IVC filter products or introducing upgraded versions of their existing products to address specific clinical needs. They are also conducting clinical trials and research studies to gather more data on the safety and efficacy of their IVC filter products. In addition, major manufacturers are working to address safety concerns related to IVC filters, such as filter migration, fracture, and perforation.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report